Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7380 p738
17 December 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacy IT must evolve for future contract needs

Key to finding the most appropriate IT system to support the new community pharmacy contract is identifying one that will evolve over time to meet both current and future needs, according to Nick Strong, managing director of Systems Solutions.

“It is important that your IT supplier has a roadmap of ideas and features that will be added to your IT system over time,” he says. “This roadmap should be reviewed regularly, with new features being added to the system at least once a year.”

Systems Solutions has carried out a survey of 400 UK pharmacists that identifies repeat dispensing, smoking cessation, minor ailments schemes, prescription intervention services, medication disposal and medicines use reviews as the services pharmacists are most interested in providing.

Mr Strong believes that there are a number of minimum features that a pharmacy IT system should have in order to provide these services.

The repeat dispensing functions should be capable of keeping track of multiple repeats and, in order to assist scheduling, be able to link repeat management to the prescription collection service.

The software should also prompt the user to ask patients whether their medicines are still required and record if any changes are made.

To enable pharmacists to identify patient groups to whom they can provide enhanced services, the system should be able to record patients’ lifestyle information, Mr Strong says. This function is also useful for running a minor ailments scheme.

The system will need to be able to register patients and be capable of storing and printing registration forms, pre-printed prescriptions and support minor ailments scheme reporting. In addition, it should contain endorsement software that is able to recognise drugs for minor ailments, he adds.

Back to Top


©The Pharmaceutical Journal